Unique ID issued by UMIN | UMIN000022287 |
---|---|
Receipt number | R000025582 |
Scientific Title | The Effect of Skin Lotion on Drying of Skin (A Four Week Trial) |
Date of disclosure of the study information | 2016/05/12 |
Last modified on | 2016/12/02 09:24:34 |
The Effect of Skin Lotion on Drying of Skin (A Four Week Trial)
The Effect of Skin Lotion on Drying of Skin
The Effect of Skin Lotion on Drying of Skin (A Four Week Trial)
The Effect of Skin Lotion on Drying of Skin
Japan |
N/A (healthy adults)
Adult |
Others
NO
This study examines the effect of 4-week usage of the test product on the skin condition.
Efficacy
[1]Skin moisture content (preliminary observation, Week 4)
[2]Transepidermal water loss (preliminary observation, Week 4)
[1]Sebum capacity (preliminary observation, Week 4)
[2]Skin pH (preliminary observation, Week 4)
[3]Visual evaluation by a medical specialist/ physician's interview (preliminary observation, Week 4)
[4]Horny layer analysis(preliminary observation, Week 4)
[5]Subjective questionnaire (preliminary observation, Week 4)
[6]Subject's diary (From the first day of using a test material to the last day of the test)
Interventional
Parallel
Non-randomized
Open -no one is blinded
Active
2
Treatment
Other |
Applying a test product A (on the left-half of the face; 1ml/day [twice a day]; 4 weeks)
Applying a test product B (on the right-half of the face; 1ml/day [twice a day]; 4 weeks)
30 | years-old | <= |
50 | years-old | > |
Female
[1]Japanese males and females aged 30-49 years
[2]Individuals who are healthy and have no chronic physical disease including skin disease
[3]Individuals who are worry about drying of skin
[4]Individuals who apply basic skin-care products with a way of the following patterns
a)unused
b)only lotion
c)lotion + milky liquid
d)lotion + beauty liquid
[5]Individuals who can change a lotion being used to a test product
[6]Individuals whose written informed consent has been obtained
[7]Individuals who can have an examination in a designated day
[8]Individuals judged appropriate for the study by the principal
[1]Individuals using medical products
[2]Individuals with skin disease, such as atopic dermatitis
[3]Individuals with strange skin conditions at measurement points
[4]Individuals who used or applied a drug for treatment of disease in the past 1 month
[5]Individuals who changed or will change skin care products during the test period in the past 2 months
[6]Individuals who have a history of applying steroidal anti-inflammatory agent for treatment of skin disease in the past 6 months
[7]Individuals who are sensitive to cosmetics
[8]Individuals who would emerge seasonal allergy and use drugs (except eye drops and nose drops)
[9]Individuals who used cosmetics or drugs improving skin moisture or tension at measurement points in the past 3 months
[10]Individuals who treated or will treat cosmetics or drugs claiming chemical peeling on measurement points in the past 3 months
[11]Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplements in the past 1 months or will ingest those foods during the test period
[12]Individuals who cannot avoid daylight exposure during the test period
[13]Individuals who had an operation at measurement point in the past 6 months
[14]Individuals who have an addiction to alcohol or a mental illness
[15]Individuals whose life style will change during the test period
[16]Individuals who participate or will participate in other clinical studies
[17]Individuals who participated in other clinical studies in the past three months
[18]Individuals who are or are possibly pregnant, or are lactating
[19]Individuals judged inappropriate for the study by the principal
23
1st name | |
Middle name | |
Last name | Shuji Nakata |
Medical Corporation Bokushinkai CLINTEXE Clinic
Director
4F Atago Green Hills Mori Tower 2-5-1 Atago Minato-ku Tokyo 105-6204, JAPAN
03-5405-1059
info@tes-h.co.jp
1st name | |
Middle name | |
Last name | Toshiyasu Tamura |
TES Holdings Co., Ltd
Department of Clinical Trial
6F University of Tokyo Entrepreneur Plaza 7-3-1 Hongo Bunkyo-ku Tokyo 113-0033, JAPAN
03-6801-8480
t.tamura@tes-h.co.jp
TES Holdings Co., Ltd
ROHTO Pharmaceutical Co., Ltd.
Profit organization
NO
2016 | Year | 05 | Month | 12 | Day |
Unpublished
Completed
2016 | Year | 04 | Month | 12 | Day |
2016 | Year | 05 | Month | 15 | Day |
2016 | Year | 05 | Month | 12 | Day |
2016 | Year | 12 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025582
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |